⌘K

Home/Filings/4/0001181431-13-015372

4//SEC Filing

Bahrt Kenneth 4

Accession 0001181431-13-015372

CIK 0000722104other

View on SEC.gov Company Profile

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:45 PM ET

Size

10.2 KB

Accession

0001181431-13-015372

Insider Transaction Report

Form 4

Period: 2013-03-05

SAVIENT PHARMACEUTICALS INCSVNT

SVP, Chief Medical Officer

Transactions

Award
Option to Purchase Common Stock
2013-03-05+110,000→ 110,000 total
Exercise: $0.94Exp: 2023-03-05→ Common Stock (110,000 underlying)
Award
Option to Purchase Common Stock
2013-03-05+90,000→ 90,000 total
Exercise: $2.26Exp: 2022-02-01→ Common Stock (90,000 underlying)
Award
Option to Purchase Common Stock
2013-03-05+50,000→ 50,000 total
Exercise: $7.00Exp: 2021-07-31→ Common Stock (50,000 underlying)

Holdings

Common Stock
179,461

Footnotes (3)

[F1]These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013.
[F2]These options reflect the vesting of performance options that were granted to the reporting person effective February 1, 2012.
[F3]These options reflect the vesting of performance options that were granted to the reporting person effective July 31, 2011.

Documents

1 file

4
rrd373115.xmlPrimary
BAHRT FORM 4

Issuer

SAVIENT PHARMACEUTICALS INC

CIK 0000722104

Entity typeother

Related Parties

1

filerCIK 0001527197

Filing Metadata

Form type: 4
Filed: Mar 6, 7:00 PM ET
Accepted: Mar 7, 4:45 PM ET
Size: 10.2 KB

View on SEC.gov